Government ContextGovernment Context
DocumentsDocuments by topicDocuments by agencyPricingLog inCreate account
Pricing
LoginCreate account
DetailsRelated

Attachment 1 - Tolmetin Capsules-OB Page

Supporting & Related MaterialFDA-2026-P-7180-0003
Document

Details

The document's own metadata, straight from the source system.

Title
Attachment 1 - Tolmetin Capsules-OB Page
Posted
Jun 29, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Supporting & Related Material
Attachment 3 - FDA-2025-P-3575
No comment periodJun 29, 2026
Other
Acknowledgement Letter from FDA DMB to Senores Pharmaceuticals, Inc.
No comment periodJun 29, 2026
Supporting & Related Material
Attachment 2 - RS approved labeling
No comment periodJun 29, 2026
Supporting & Related Material
Attachment 4 - Proposed labeling for Tolmetin Capsules 600 mg
No comment periodJun 29, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies using data from regulations.gov.

ExploreDocumentsTopicsAgencies
CompanyAboutPricing
LegalPrivacyTerms
© 2026 Government Context. Built on data from regulations.gov.Not affiliated with any U.S. government agency.